Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01448850
Other study ID # CD-RI-MEDI8968-1103
Secondary ID
Status Completed
Phase Phase 2
First received October 6, 2011
Last updated March 31, 2014
Start date November 2011
Est. completion date February 2014

Study information

Verified date March 2014
Source MedImmune LLC
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease


Description:

A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease


Recruitment information / eligibility

Status Completed
Enrollment 464
Est. completion date February 2014
Est. primary completion date February 2014
Accepts healthy volunteers No
Gender Both
Age group 45 Years to 80 Years
Eligibility Inclusion Criteria:

- Age 45 through 75 years.

- Predicted (GOLD stage II, III, and IV) at screening.

- History of previous AECOPD 12 months prior to screening Clinically stable and free from an AECOPD for 8 weeks prior to Day 1.

- Current smoker or ex-smoker with a tobacco history of = 10 pack-years

Exclusion Criteria:

- Past or present disease or disorder,

- Significant or unstable ischemic heart disease, etc

- Known history of allergy or reaction to any component of the IMP

- Past or current malignancy within the past 5 years

- Subjects have had a chest x-ray or CT scan suggestive of malignancy or tuberculosis (TB).

- Use of immunosuppressive medication receipt of any biologic agent

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Biological:
MEDI8968 SC for 12 months
Drug
Placebo SC for 12 months
Simulated medical intervention

Locations

Country Name City State
Bulgaria Research Site Plovdiv
Bulgaria Research Site Ruse
Bulgaria Research Site Sofia
Bulgaria Research Site Stara Zagora
Bulgaria Research Site Veliko Tarnovo
Czech Republic Research Site Brno
Czech Republic Research Site Jindrichuv Hradec
Czech Republic Research Site Karlovy Vary
Czech Republic Research Site Plzen
Czech Republic Research Site Praha 10
Czech Republic Research Site Strakonice
Hungary Research Site Balassagyarmat
Hungary Research Site Budapest
Hungary Research Site Farkasgyepü
Hungary Research Site Komarom
Hungary Research Site Mateszalka
Hungary Research Site Matrahaza
Hungary Research Site Mosonmagyarovar
Hungary Research Site Nagykanizsa
Hungary Research Site Szikszo
Hungary Research Site Tatabanya
Hungary Research Site Torokbalint
Latvia Research Site Daugavpils
Latvia Research Site Riga
Lithuania Research Site Kaunas
Lithuania Research Site Klaipeda
Lithuania Research Site Vilnius
Philippines Research Site Iloilo City
Philippines Research Site Lipa City
Philippines Research Site Quezon City
Poland Research Site Bialystok
Poland Research Site Gdansk
Poland Research Site Krakow
Poland Research Site Lodz
Poland Research Site Oswiecim
Poland Research Site Poznan
Poland Research Site Wroclaw
Poland Research Site Zgierz
Ukraine Research Site Ivano-Frankivsk
Ukraine Research Site Kharkiv
Ukraine Research Site Kyiv
Ukraine Research Site Odessa
Ukraine Research Site Poltava
Ukraine Research Site Simferopol
Ukraine Research Site Vinnytsya
United Kingdom Research Site Cambridge
United Kingdom Research Site Newcastle upon Tyne
United Kingdom Research Site Wolverhampton
United States Research Site Auburn Maine
United States Research Site Boerne Texas
United States Research Site Buffalo New York
United States Research Site Charlotte North Carolina
United States Research Site Cincinnati Ohio
United States Research Site Clearwater Florida
United States Research Site Duluth Georgia
United States Research Site Greenville South Carolina
United States Research Site Oklahoma City Oklahoma
United States Research Site Peoria Arizona
United States Research Site Phoenix Arizona
United States Research Site Richmond Virginia
United States Research Site Spartanburg South Carolina

Sponsors (1)

Lead Sponsor Collaborator
MedImmune LLC

Countries where clinical trial is conducted

United States,  Bulgaria,  Czech Republic,  Hungary,  Latvia,  Lithuania,  Philippines,  Poland,  Ukraine,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary To evaluate the effect of MEDI8968 on the rate of acute exacerbations of COPD (AECOPD) in adult subjects with COPD; GOLD II-IV on standard maintenance therapy Approximately 12 months Yes
See also
  Status Clinical Trial Phase
Completed NCT05102305 - A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
Completed NCT01867762 - An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Phase 2
Recruiting NCT05562037 - Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA N/A
Terminated NCT04921332 - Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD N/A
Completed NCT03089515 - Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust N/A
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT05552833 - Pulmonary Adaptive Responses to HIIT in COPD N/A
Recruiting NCT05835492 - A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
Recruiting NCT05631132 - May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases? N/A
Completed NCT03244137 - Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
Not yet recruiting NCT03282526 - Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease N/A
Completed NCT02546700 - A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 2
Withdrawn NCT04446637 - Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD Phase 3
Completed NCT04535986 - A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD Phase 3
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Completed NCT03256695 - Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT03295474 - Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
Withdrawn NCT04042168 - Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT03414541 - Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease Phase 2
Completed NCT02552160 - DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy